Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Killer Cells, Natural | 5 | 2024 | 2200 | 0.700 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2024 | 1351 | 0.670 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8503 | 0.390 |
Why?
|
Cobalt | 1 | 2011 | 154 | 0.380 |
Why?
|
Zinc | 1 | 2011 | 687 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5253 | 0.280 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 321 | 0.190 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2522 | 0.170 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 304 | 0.160 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 16881 | 0.160 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5129 | 0.150 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1824 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3573 | 0.140 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 632 | 0.140 |
Why?
|
Francisella tularensis | 1 | 2016 | 62 | 0.130 |
Why?
|
Interleukin-2 | 1 | 2022 | 1890 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1354 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13597 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1247 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2378 | 0.110 |
Why?
|
Carbon | 1 | 2016 | 664 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1890 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1888 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2011 | 193 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2891 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2011 | 656 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.080 |
Why?
|
Genome, Human | 1 | 2021 | 4414 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2472 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2016 | 2100 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4624 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4872 | 0.070 |
Why?
|
Proteome | 1 | 2016 | 1852 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5489 | 0.060 |
Why?
|
Doxorubicin | 1 | 2011 | 2211 | 0.060 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1454 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5648 | 0.060 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 468 | 0.050 |
Why?
|
Genomics | 3 | 2023 | 5788 | 0.050 |
Why?
|
Mice | 4 | 2024 | 81066 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5732 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2021 | 67 | 0.050 |
Why?
|
Oxygen | 1 | 2011 | 4190 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10167 | 0.040 |
Why?
|
Animals | 5 | 2024 | 167718 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1254 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12601 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2024 | 1353 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2021 | 719 | 0.030 |
Why?
|
Apoptosis | 1 | 2011 | 9466 | 0.030 |
Why?
|
Bacterial Load | 1 | 2016 | 151 | 0.030 |
Why?
|
Humans | 10 | 2024 | 757566 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1739 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2016 | 751 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21986 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4808 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6128 | 0.030 |
Why?
|
Signal Transduction | 2 | 2016 | 23335 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 786 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8426 | 0.020 |
Why?
|
Epitopes | 1 | 2016 | 2502 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12951 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4641 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16533 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5781 | 0.020 |
Why?
|
Female | 2 | 2024 | 389943 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 6024 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9163 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2867 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2796 | 0.020 |
Why?
|
Pyrimidines | 1 | 2016 | 3005 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9245 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4350 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3839 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3583 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3809 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21990 | 0.010 |
Why?
|
Child | 1 | 2022 | 79782 | 0.010 |
Why?
|
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_